You are here » Home » Companies » Company Overview » Beta Drugs Ltd

Beta Drugs Ltd.

BSE: 535022 Sector: Health care
NSE: BETA ISIN Code: INE351Y01019
BSE 05:30 | 01 Jan Beta Drugs Ltd
NSE 00:00 | 18 Mar 88.00 0
(0.00%)
OPEN

89.10

HIGH

90.40

LOW

88.00

OPEN
PREVIOUS CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty
OPEN
CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty
Filter:

Beta Drugs Ltd. (BETA) - Yearly Result

Particulars ( cr) Mar '18 Mar '17
Net Sales/Income From Operations 50.57 41.65
Other Income 0.24 0.03
Total Income 50.81 41.68
Total Expenditure 41.11 34.37
Operating Profit 9.70 7.31
Interest 1.01 0.82
Gross Profit 8.69 6.49
Depreciation 1.85 1.24
PBT 6.83 5.25
Tax 0.07 1.07
Net Profit/(Loss) 6.76 4.27
Minority Interest After NP - -
Net Profit after Minority Interest - -
Exceptional Items 0.00 0.00
Profit After Exceptional Items 6.76 4.27
Equity Share Capital 8.65 1.01
Reserves Excluding Revaluation Reserves 24.23 5.06
EPS
Basic EPS 7.82 42.27
Public Share Holding
No Of Shares (Crores) 0 0
Share Holding (%) 0.00 0.00
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of Shares (Crores) 0 0
- Per. of Shares (as a % of the total sh. of prom. and promoter group) 0.00 0.00
- Per. of Shares (as a % of the total Share Cap. of the company) 0.00 0.00
b) Non-encumbered
- Number of Shares (Crores) 0 0
- Per. of shares (as a % of the total sh. of prom. and promoter group) 0.00 0.00
- Per. of shares (as a % of the total Share Cap. of the company) 0.00 0.00
Note : PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure.